The 8th annual Microbiome Connect: USA will return in November 2023, showcasing the leading drug development platforms applying microbes, microbe modulators and microbial-derived components to prevent or treat human diseases or make medical diagnosis.
At Microbiome Connect you will hear from microbiome biotechs, pharma voices, investment bodies, and more on how to develop robust, scalable, and reproducible formulations for microbe-derived/-targeting products entering late-stage investigations and reaching for the market.
Be sure to register your interest to be the first to receive the latest updates and news from the series!
The DIA Innovating Clinical Trials in Europe virtual conference delves into initiatives like Accelerating Clinical Trials EU and AI's role in medicines development. Ethical considerations, regulatory perspectives, Real-World Evidence, and patient-centric approaches are discussed. Explore EU PEARL's master protocol studies and how Digital Health Technologies aid patient identification, recruitment, and innovative trial design.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our